Appraisal of Cognition in Preclinical Alzheimer’s Disease: A Conceptual Review
Year: 2012
Type: article
Abstract: Biomarker evidence and clinical observations support the hypothesis that there is a diagnosable condition termed preclinical Alzheimer's disease (AD). Recently, a workgroup convened under the auspices of the National Institute on Aging and the Alzheimer's Association proposed a framework for defining preclinical AD. The definition was based on the presence of biomarkers that are indicative of the AD pathophysiological process. In the context of abnormal AD biomarkers, the workgroup postulated that 'subtle cognitive changes' occurred as well. Based on studies of genetically at-risk individuals and those destined to become demented, who were observed while still cognitively normal, low performance on learning and memory functions may be the earliest cognitive manifestations of preclinical AD, at the group level at least. It is not clear whether subtle cognitive decline can be detected reliably on an individual basis. Preclinical AD cognitive changes could be diagnosed by traditional neuropsychological testing, computerized testing, assessments of subjective memory loss, assessments of levels of participation in cognitively stimulating activities and direct measurement of activity using recently developed monitoring technology. Confounding effects of normal aging, test-retest variability, variations in educational attainment, as well as the presence of other brain diseases make diagnosing cognitive decline due to preclinical AD challenging.
DOI: 10.2217/nmt.12.5
Authors: David S Knopman, Richard J Caselli
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: preclinical Alzheimer's disease, cognitive decline, learning and memory impairment, Alzheimer's disease biomarkers, neuropsychological assessment, subjective memory complaints, cognitively stimulating activities, normal aging, test-retest variability, educational attainment, genetic risk, dementia risk
Open Access status: green
Funders: Mayo Clinic, National Institute on Aging
OpenAlex ID: W2125334134
